Deep Track Capital, LP 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 08:46 am Purchase | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital, LP | 3,600,000 8.460% | 600,000 (+20.00%) | Filing |
| 2025-11-14 08:23 am Purchase | 2025-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital, LP | 3,000,000 7.110% | 647,040 (+27.50%) | Filing |
| 2025-07-28 5:00 pm Purchase | 2025-07-21 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital, LP | 2,352,960 5.600% | 2,352,960 (New Position) | Filing |